Public Company

Foghorn Therapeutics

At Foghorn Therapeutics, we are leveraging our unique insights into this fundamental system to pioneer a new class of precision therapies in oncology and beyond.


Foghorn Therapeutics is a clinical-stage biotechnology company pioneering a new class of medicines designed to modulate the chromatin regulatory system, which functions to orchestrate the genes our cells express — as well as when, where, and in what order. Using our Gene Traffic Control® proprietary platform, we are rapidly advancing over 10 programs across a wide range of cancers — and aim to explore treatments for other diseases. Our two lead product candidates entered the clinic in 2021.


Founded 2016
Type Public
Longevity related Yes
Location Cambridge, Massachusetts, USA

Recent Jobs at Foghorn Therapeutics

Latest News